Literature DB >> 21883915

Specificity of histological markers of long-term CNI nephrotoxicity in kidney-transplant recipients under low-dose cyclosporine therapy.

R Snanoudj1, V Royal, C Elie, M Rabant, C Girardin, E Morelon, H Kreis, J-C Fournet, L-H Noël, C Legendre.   

Abstract

The specificity of chronic histological lesions induced by calcineurin inhibitors (CNI) is often questioned, but few studies have directly compared long-term lesions in renal-transplant patients who received this treatment and those who did not. We therefore conducted a retrospective study of 141 kidney-transplant recipients treated with (n = 48) or without (n = 93) cyclosporine (CsA) to compare the histological lesions observed at 3-month, 24-month and 10-year protocol biopsies. All of the chronic elementary lesions (glomerulosclerosis, interstitial fibrosis, tubular atrophy, arteriolar hyalinosis, fibrointimal thickening) progressed in frequency and severity in both groups, although significantly more in the CsA group. Ten-year biopsy results showed that 92% of patients in the CsA-treated group and 65% in the control group had arteriolar hyalinosis lesions. When we focused on muscular arteriolar hyaline deposits more specific to CsA arteriolopathy, we observed these lesions in 68% of CsA patients and 28% of patients who had never received CsA. CsA was not the sole factor involved in the development of arteriolar hyalinosis and was independently associated with an increased risk of graft loss. In summary, we observed that histological lesions commonly attributed to CsA nephrotoxicity were not sufficiently specific to definitively diagnose CNI nephrotoxicity. ©Copyright 2011 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21883915     DOI: 10.1111/j.1600-6143.2011.03718.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  27 in total

Review 1.  The impact of donor-specific anti-HLA antibodies on late kidney allograft failure.

Authors:  Alexandre Loupy; Gary S Hill; Stanley C Jordan
Journal:  Nat Rev Nephrol       Date:  2012-04-17       Impact factor: 28.314

2.  Banff 2011 Meeting report: new concepts in antibody-mediated rejection.

Authors:  M Mengel; B Sis; M Haas; R B Colvin; P F Halloran; L C Racusen; K Solez; L Cendales; A J Demetris; C B Drachenberg; C F Farver; E R Rodriguez; W D Wallace; D Glotz
Journal:  Am J Transplant       Date:  2012-02-02       Impact factor: 8.086

Review 3.  Is it time to give up with calcineurin inhibitors in kidney transplantation?

Authors:  Maurizio Salvadori; Elisabetta Bertoni
Journal:  World J Transplant       Date:  2013-06-24

4.  Vasa recta hyalinosis reflects severe arteriolopathy in renal allografts.

Authors:  Hideyo Oguchi; Ken Sakai; Yutaka Yamaguchi; Tetuo Mikami; Tetsuo Nemoto; Yasushi Ohashi; Takeshi Kawamura; Masaki Muramatsu; Yoshihiro Itabashi; Kazunobu Shinoda; Yoji Hyodo; Yusuke Takahashi; Yuki Kawaguchi; Hiroka Onishi; Yuko Hamasaki; Kazutoshi Shibuya; Seiichiro Shishido
Journal:  Clin Exp Nephrol       Date:  2019-02-08       Impact factor: 2.801

5.  Non-immunologic allograft loss in pediatric kidney transplant recipients.

Authors:  Isa F Ashoor; Vikas R Dharnidharka
Journal:  Pediatr Nephrol       Date:  2018-02-26       Impact factor: 3.714

Review 6.  Clinical role of the renal transplant biopsy.

Authors:  Winfred W Williams; Diana Taheri; Nina Tolkoff-Rubin; Robert B Colvin
Journal:  Nat Rev Nephrol       Date:  2012-01-10       Impact factor: 28.314

7.  Infiltrating cellular pattern in kidney graft biopsies translates into forkhead box protein 3 up-regulation and p16INK4α senescence protein down-regulation in patients treated with belatacept compared to cyclosporin A.

Authors:  J Furuzawa-Carballeda; G Lima; J Alberú; D Palafox; N Uribe-Uribe; L E Morales-Buenrostro; R Reyes Acevedo; G Mondragón; A Chevaile; L Llorente
Journal:  Clin Exp Immunol       Date:  2012-02       Impact factor: 4.330

Review 8.  Calcineurin inhibitor sparing strategies in renal transplantation, part one: Late sparing strategies.

Authors:  Andrew Scott Mathis; Gwen Egloff; Hoytin Lee Ghin
Journal:  World J Transplant       Date:  2014-06-24

9.  Tacrolimus trough levels after month 3 as a predictor of acute rejection following kidney transplantation: a lesson learned from DeKAF Genomics.

Authors:  Ajay K Israni; Samy M Riad; Robert Leduc; William S Oetting; Weihua Guan; David Schladt; Arthur J Matas; Pamala A Jacobson
Journal:  Transpl Int       Date:  2013-07-24       Impact factor: 3.782

Review 10.  Current status of pediatric renal transplant pathology.

Authors:  Jan U Becker
Journal:  Pediatr Nephrol       Date:  2016-05-24       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.